| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
87,300,000 |
| Market
Cap: |
18.04(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2066 - $0.2066 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Agile Therapeutics is a women's healthcare company. Co.'s primary product candidate, Twirla, is a once-weekly prescription combination hormonal contraceptive patch. It delivers a dose of estrogen that is consistent with commonly prescribed combined hormonal contraceptives. Co.'s pipeline consists of two classes of product candidates: Co.'s potential product pipeline consists of two types of product candidates: a progestin-only contraceptive patch and potential Twirla line extensions. These potential product candidates are designed to address market needs and provide additional non-daily contraceptive options. Including AG200-15 Extended Regimen, AG200-SmP, and AG200-15 ER SmP.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Altomari Alfred |
Chairman and Chief Executive O |
• • – |
2017-05-11 |
4 |
B |
$3.51 |
$35,100 |
D/D |
10,000 |
151,587 |
2.81 |
- |
|
| Altomari Alfred |
Chairman & Chief Exec Officer |
• • – |
2017-04-11 |
4 |
OE |
$1.76 |
$52,800 |
D/D |
30,000 |
141,587 |
|
- |
|
| Altomari Alfred |
Chief Executive Officer |
• • – |
2017-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,667 |
111,587 |
|
- |
|
| Schiff Dr Drew |
10% Owner |
– – • |
2016-06-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(400,000) |
2,583,797 |
|
- |
|
| Altomari Alfred |
Chief Executive Officer |
• • – |
2016-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,666 |
94,920 |
|
- |
|
| Proquest Associates Iv Llc |
10% Owner |
– – • |
2016-01-27 |
4 |
B |
$6.35 |
$2,499,995 |
I/I |
393,700 |
5,062,363 |
1.5 |
- |
|
| Altomari Alfred |
Chief Executive Officer |
• • – |
2015-06-02 |
4 |
B |
$8.73 |
$21,825 |
D/D |
2,500 |
78,254 |
2.81 |
- |
|
| Altomari Alfred |
Chief Executive Officer |
• • – |
2015-03-11 |
4 |
OE |
$1.76 |
$30,800 |
D/D |
17,500 |
75,754 |
|
- |
|
| Schiff Dr Drew |
Director |
– • • |
2015-01-23 |
4 |
B |
$5.85 |
$4,750,001 |
I/I |
811,966 |
2,983,797 |
2.25 |
- |
|
| Proquest Associates Iv Llc |
10% Owner |
– – • |
2015-01-23 |
4 |
B |
$5.85 |
$4,750,001 |
I/I |
811,966 |
4,668,663 |
1.5 |
- |
|
| Altomari Alfred |
Chief Executive Officer |
• • – |
2014-12-18 |
4 |
OE |
$1.76 |
$52,800 |
D/D |
30,000 |
58,254 |
|
- |
|
| Proquest Associates Iv Llc |
10% Owner |
– – • |
2014-05-29 |
4 |
B |
$6.00 |
$6,724,998 |
I/I |
1,120,833 |
3,856,697 |
1.5 |
- |
|
| Proquest Associates Iv Llc |
10% Owner |
– – • |
2014-05-29 |
4 |
A |
$0.00 |
$949,044 |
I/I |
2,733,141 |
2,735,864 |
|
- |
|
| Care Capital Offshore Investments Iii Lp |
10% Owner |
– – • |
2014-05-29 |
4 |
B |
$6.00 |
$3,000,000 |
I/I |
500,000 |
3,010,189 |
1.5 |
- |
|
| Care Capital Offshore Investments Iii Lp |
10% Owner |
– – • |
2014-05-29 |
4 |
A |
$0.00 |
$0 |
I/I |
2,510,189 |
2,510,189 |
|
- |
|
| Investor Ab |
10% Owner |
– – • |
2014-05-29 |
4 |
B |
$6.00 |
$15,059,694 |
I/I |
2,509,949 |
3,509,949 |
1.5 |
- |
|
| Elms Steve |
10% Owner |
– – • |
2014-05-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,171,831 |
|
- |
|
| Schiff Dr Drew |
Director |
– • • |
2014-05-23 |
4 |
B |
$6.00 |
$7,999,998 |
I/I |
1,333,333 |
2,171,831 |
2.25 |
- |
|
| Investor Ab |
10% Owner |
– – • |
2014-05-22 |
4 |
B |
$6.00 |
$6,000,000 |
I/I |
1,000,000 |
1,000,000 |
1.5 |
- |
|
| Altomari Alfred |
Chief Executive OfficerOfficer |
• • – |
2014-05-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,254 |
|
- |
|
| Coiante Scott M |
VP and Chief Financial Officer |
• – – |
2014-05-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,939 |
|
- |
|
| Proquest Associates Iv Llc |
10% Owner |
– – • |
2014-05-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,723 |
|
- |
|
122 Records found
|
|
Page 5 of 5 |
|
|
